Karen G.
- Country
- Belgium
- Department
- Gastroenterology
Research Overview
- A Randomized, Double-blind, Placebo-controlled Phase 3 Trial of Pembrolizumab (MK-3475) Versus Placebo in Participants with Esophageal Carcinoma Receiving Concurrent Definitive Chemoradiotherapy (KEYNOTE 975)
- Sotorasib and Combination Therapy Versus Standard Chemotherapy in Treatment-Naïve Patients with KRAS p.G12C-Mutated Metastatic Colorectal Cancer
- Phase 3 Randomized Double-Blind Study of INCA33890 Plus First-Line Chemotherapy and Bevacizumab in Metastatic Microsatellite Stable Colorectal Cancer
Data & Insights
Has run more than one trial at 260 of 453 partner sites.
Specializations
Gastrointestinal Oncology
This investigator specializes in treating various forms of gastrointestinal cancers, with particular focus on advanced and metastatic conditions.
- Colorectal Cancer Management
- Gastroesophageal Cancer Treatment
- Pancreatic Cancer Therapy
The investigator works extensively with targeted therapies and immunotherapy approaches for gastrointestinal malignancies.
Specialized Cancer Types
Focuses on treating rare and complex forms of gastrointestinal tract cancers requiring specialized therapeutic approaches.
- Neuroendocrine Tumors
- Cholangiocarcinoma
- Pancreatic Ductal Adenocarcinoma
Employs multimodal treatment strategies including combinations of chemotherapy, radiation, and targeted agents.
Treatment Innovations
Implements cutting-edge therapeutic approaches in gastrointestinal oncology.
- Novel Drug Combinations
- Personalized Medicine Approaches
- Advanced Imaging Techniques
Specializes in molecular targeted therapies and biomarker-driven treatment selection.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.